MX2023003360A - Metodos de tratamiento de trastornos asociados a la via del receptor de melanocortina-4. - Google Patents

Metodos de tratamiento de trastornos asociados a la via del receptor de melanocortina-4.

Info

Publication number
MX2023003360A
MX2023003360A MX2023003360A MX2023003360A MX2023003360A MX 2023003360 A MX2023003360 A MX 2023003360A MX 2023003360 A MX2023003360 A MX 2023003360A MX 2023003360 A MX2023003360 A MX 2023003360A MX 2023003360 A MX2023003360 A MX 2023003360A
Authority
MX
Mexico
Prior art keywords
methods
associated disorders
receptor pathway
melanocortin
treating
Prior art date
Application number
MX2023003360A
Other languages
English (en)
Inventor
Der Ploeg Leonardus H T Van
Alastair Garfield
Bhavik P Shah
Original Assignee
Rhythm Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhythm Pharmaceuticals Inc filed Critical Rhythm Pharmaceuticals Inc
Publication of MX2023003360A publication Critical patent/MX2023003360A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

La descripción está relacionada con un método para tratar un trastorno, trastorno o afección asociados a un gen agonizable de la vía del MC4R, tal como obesidad o hiperfagia, en un sujeto que usa un agonista del receptor de melanocortina-4 (MC4R).
MX2023003360A 2020-09-24 2021-09-24 Metodos de tratamiento de trastornos asociados a la via del receptor de melanocortina-4. MX2023003360A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063082867P 2020-09-24 2020-09-24
PCT/US2021/052032 WO2022067086A1 (en) 2020-09-24 2021-09-24 Methods of treating melanocortin-4 receptor pathway-associated disorders

Publications (1)

Publication Number Publication Date
MX2023003360A true MX2023003360A (es) 2023-06-23

Family

ID=80845850

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023003360A MX2023003360A (es) 2020-09-24 2021-09-24 Metodos de tratamiento de trastornos asociados a la via del receptor de melanocortina-4.

Country Status (13)

Country Link
US (1) US20240058414A1 (es)
EP (1) EP4216979A1 (es)
JP (1) JP2023542985A (es)
KR (1) KR20230095956A (es)
CN (1) CN116507353A (es)
AR (1) AR123603A1 (es)
AU (1) AU2021350017A1 (es)
CA (1) CA3192873A1 (es)
CL (1) CL2023000823A1 (es)
CO (1) CO2022009561A2 (es)
MX (1) MX2023003360A (es)
TW (1) TW202228760A (es)
WO (1) WO2022067086A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024015880A2 (en) * 2022-07-12 2024-01-18 Rhythm Pharmaceuticals, Inc. Methods for treating obesity with an mc4r agonist

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101257916B (zh) * 2005-07-08 2013-04-03 益普生制药股份有限公司 黑皮质素受体配体
CN108601816A (zh) * 2015-09-30 2018-09-28 节奏制药公司 治疗黑皮质素-4受体路径相关联病症的方法

Also Published As

Publication number Publication date
AR123603A1 (es) 2022-12-21
CL2023000823A1 (es) 2023-09-15
WO2022067086A1 (en) 2022-03-31
CO2022009561A2 (es) 2022-07-19
CA3192873A1 (en) 2022-03-31
KR20230095956A (ko) 2023-06-29
TW202228760A (zh) 2022-08-01
EP4216979A1 (en) 2023-08-02
AU2021350017A1 (en) 2023-05-04
CN116507353A (zh) 2023-07-28
JP2023542985A (ja) 2023-10-12
US20240058414A1 (en) 2024-02-22

Similar Documents

Publication Publication Date Title
EP4234584A3 (en) Heterodimer molecule based on ch3 structural domain, and preparation method therefor and use thereof
MX2022010425A (es) Metodos de tratamiento de enfermedades asociadas a los receptores de estrogenos.
MX2023003358A (es) Agonista del receptor de melanocortina-4 (mc4r) para el tratamiento de trastornos asociados a la via del mc4r.
EA201690117A1 (ru) Способ крекинга углеводородного сырья в установке парового крекинга
MY189778A (en) Method for producing retinal pigment epithelial cells
WO2018132635A8 (en) Methods for analyzing t cell receptors and b cell receptors
MX2023003360A (es) Metodos de tratamiento de trastornos asociados a la via del receptor de melanocortina-4.
NO20084486L (no) Vanninjeksjonssystemer og -metoder
MX2021010193A (es) Azepino-indoles y otros heterociclos para el tratamiento de trastornos cerebrales.
SA517390453B1 (ar) عملية من أجل فصل رواسب لإنتاج زيوت وقود
GB2528586A (en) Treatment of a subterranean formation with composition including a microorganism or compound generated by the same
MX2021009886A (es) Enzimas con dominios ruvc.
GB2460968A (en) Method and system for recovering aromatics from a naphtha feedstock
EP4071469A3 (en) Methods and systems for chromatography data analysis
GB2537489A (en) Real-time risk prediction during drilling operations
WO2007092596A3 (en) Methods and apparatus for predicting the hydrocarbon production of a well location
DE602007012159D1 (de) Verfahren zum individuellen anpassen eines hörgeräts oder einer hörhilfe
MX2023004443A (es) Modulacion del receptor acoplado a proteina g (gpcr) por imipridones.
TW200640931A (en) Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
NO20083433L (no) Avleiringshemmende bronnbehandling
MX2016003840A (es) Prediccion de riesgo en tiempo real durante las operaciones de perforacion.
BR112014016847A2 (pt) método e sistema para codificar dados de áudio com compensação de baixa frequênciaadaptável
MX2022000893A (es) Metodo de obtencion de mitocondrias de celulas y mitocondrias obtenidas.
EA033166B1 (ru) Способ конверсии углеводородов в олефины
NO20090661L (no) Fremgangsmate for a fjerne forurensninger fra produsert vann